While an overexpression of gal-3 in PDAC tissues and a gal-3-mediated suppression of CD8 TILs have been already described, the gal-3 concentrations in the serum of pancreatic cancer patients is discussed controversially (8, 9, 41, 42). The gene discussed is CD8A; the disease is familial pancreatic carcinoma.